Jiaqi He

Nov 12, 2024 | biorxiv.org | Jiaqi He |Hang Hu |Xiaoyu Wu |Ziheng Zhu

AbstractDue to the inevitable progression to castration-resistant prostate cancer (CRPC) following treatment with androgen deprivation therapy (ADT), it is essential to develop novel treatment approaches for managing CRPC. Here we showed that metalloproteinase TLL1 was positively associated with prostate cancer aggressiveness. Mechanistically, TLL1 promoted prostate cancer cells migration and metastasis through cleaving latent TGF-β1 to activate TGF-β signaling pathway.

Nov 6, 2024 | pubs.acs.org | Xianbin Ma |Mingchuan Mao |Zhenya Liu |Jiaqi He

Nov 6, 2024 | dx.doi.org | Xianbin Ma |Mingchuan Mao |Zhenya Liu |Jiaqi He

Oct 17, 2024 | mdpi.com | Xin Huang |Jiaqi He |Dangchen Sui |Liuyang Yao

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

May 24, 2024 | mdpi.com | Jie Zheng |Shuang Li |Jiaqi He |Hao Liu

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.